Vigabatrin add‐on therapy for drug‐resistant focal epilepsy

Review of 11 trials (n=756) found that vigabatrin may significantly reduce seizure frequency in people with drug‐resistant focal epilepsy. The results largely apply to adults and should not be extrapolated to children under 10 years old.

Source:

Cochrane Database of Systematic Reviews